Capital Advisors Ltd’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $53K | Hold |
162
| – | – | 0.01% | 456 |
|
|
2025
Q1 | $44K | Hold |
162
| – | – | 0.01% | 481 |
|
|
2024
Q4 | $38K | Hold |
162
| – | – | ﹤0.01% | 501 |
|
|
2024
Q3 | $45K | Hold |
162
| – | – | 0.01% | 469 |
|
|
2024
Q2 | $39K | Buy |
162
+2
| +1% | +$481 | 0.01% | 484 |
|
|
2024
Q1 | $24K | Buy |
160
+2
| +1% | +$300 | ﹤0.01% | 554 |
|
|
2023
Q4 | $30K | Sell |
158
-15
| -9% | -$2.85K | ﹤0.01% | 498 |
|
|
2023
Q3 | $31K | Buy |
173
+15
| +9% | +$2.69K | ﹤0.01% | 479 |
|
|
2023
Q2 | $30K | Buy |
158
+148
| +1,480% | +$28.1K | ﹤0.01% | 498 |
|
|
2023
Q1 | $2K | Sell |
10
-158
| -94% | -$31.6K | ﹤0.01% | 861 |
|
|
2022
Q4 | $2K | Buy |
168
+151
| +888% | +$1.8K | ﹤0.01% | 816 |
|
|
2022
Q3 | $3K | Buy |
+17
| New | +$3K | ﹤0.01% | 717 |
|
|
2022
Q2 | – | Sell |
-4
| Closed | -$1K | – | 978 |
|
|
2022
Q1 | $1K | Buy |
4
+3
| +300% | +$750 | ﹤0.01% | 665 |
|
|
2021
Q4 | $0 | Buy |
+1
| New | – | ﹤0.01% | 799 |
|